Log In
Print
BCIQ
Print
Print this Print this
 

IMAB362

Also known as: Claudiximab

  Manage Alerts
Collapse Summary General Information
Company Ganymed Pharmaceuticals AG
DescriptionMAb targeting cell surface antigen CLND18.2
Molecular Target CLND18.2
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today